Panagora Asset Management Inc Apellis Pharmaceuticals, Inc. Transaction History
Panagora Asset Management Inc
- $20.5 Billion
- Q3 2024
A detailed history of Panagora Asset Management Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 29,386 shares of APLS stock, worth $892,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,386
Previous 23,640
24.31%
Holding current value
$892,452
Previous $906,000
6.51%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding APLS
# of Institutions
300Shares Held
112MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$473 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$361 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$337 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$176 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.34B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...